| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.0026 | 0.9 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.0026 | 1 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | -0.0023 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.0024 | 1 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |